In biopsies taken at a median of 12 weeks and after only three doses results from Part A of MOMENTUM study found that the 30 mgkg of SRP5051 dosed monthly resulted in 18 times the exon skipping and eight times the dystrophin production as eteplirsen dosed weekly for 24 weeks